TNF Pharmaceuticals, Inc. (TNFA) — Capital Reinvestment Ratio
Latest as of December 2008:
0.44x
TNF Pharmaceuticals, Inc. (TNFA) has a Capital Reinvestment Ratio of 0.44x as of December 2008, meaning it reinvests 0% of its operating cash flow ($469.37K) in capital expenditures ($208.51K). See TNFA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.44x
Capex / Operating Cash Flow
Operating Cash Flow
$469.37K
USD
Capital Expenditures
$208.51K
USD
Data as of
Dec 2008
Most recent filing
TNF Pharmaceuticals, Inc. Capital Reinvestment Ratio (2007–2008)
This chart tracks TNF Pharmaceuticals, Inc.'s Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for TNF Pharmaceuticals, Inc. (2007–2008)
Year-by-year Capital Reinvestment Ratio for TNF Pharmaceuticals, Inc. from 2007 to 2008. For live market cap and broader valuation context, see TNF Pharmaceuticals, Inc. market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.44x | $469.37K | $208.51K | ▲ +285.6% |
| 2007 | 0.12x | $182.19K | $20.99K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow